LarmorBio to present clinical data with Quest Diagnostics at the World Congress on Insulin Resistance

We’re excited to share that our CMO, Michael J. McPhaul, MD, will present clinical data from our collaboration with Quest Diagnostics at the 24th World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Dec 3–5, Los Angeles).
The talk will highlight a novel blood test that captures the earliest transitions in metabolic health—opening a new window into early disease detection and personalized intervention.
Looking forward to connecting in LA.